Display options
Share it on

J Glob Infect Dis. 2017 Jan-Mar;9(1):23-30. doi: 10.4103/0974-777X.199994.

Lyell's Syndrome and Antimalarials: A Case Report and Clinical Review.

Journal of global infectious diseases

Joana Miranda Nunes, Sofia Santareno, Lina Guerreiro, Ana Filipa Margalho

Affiliations

  1. Department of Anesthesiology, Funchal Central Hospital, Madeira, Portugal.
  2. Department of Plastic Surgery and Burn Unit, North Lisbon Hospital Centre, Lisboa University Medical School, Lisboa, Portugal.
  3. Department of Anesthesiology, Pain and Emergency Medicine, North Lisbon Hospital Centre, Lisboa University Medical School, Lisboa, Portugal.
  4. Department of Plastic, Reconstructive and Aesthetic Surgery, Oncology Portuguese Institute Francisco Gentil, Lisboa, Portugal.

PMID: 28250622 PMCID: PMC5330040 DOI: 10.4103/0974-777X.199994

Abstract

Toxic epidermal necrolysis (TEN) or Lyell's syndrome is a rare, however, life-threatening mucocutaneous disorder with an epidermal detachment of a total body surface area (TBSA) of >30%. It is triggered by an idiosyncratic immune-allergic reaction to a drug, with many possible drugs implicated. Treatment success relies on early diagnosis and withdrawal of suspected/causative drug(s) and supportive care. Clinical evidence for specific therapies is still sparse. It is described a case of Lyell syndrome by sulfonamides for chemoprophylaxis of malaria. The patient presented with an extensive, rapidly evolving skin detachment, which progressed, despite supportive therapy, involving about 80% of TBSA. This led us to initiate a course of immunoglobulin with good clinical response. The aim of this work is to provide a discussion of the case and simultaneously make a practical literature review of TEN.

Keywords: Immunoglobulin; Lyell syndrome; malaria; sulfonamides; toxic epidermal necrolysis

Conflict of interest statement

There are no conflicts of interest.

References

  1. Arch Dermatol. 2000 Mar;136(3):323-7 - PubMed
  2. J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1039-58 - PubMed
  3. J Allergy Clin Immunol. 2000 Dec;106(6):1171-6 - PubMed
  4. Science. 1998 Oct 16;282(5388):490-3 - PubMed
  5. Dermatol Surg. 2003 Feb;29(2):185-8 - PubMed
  6. J Am Acad Dermatol. 1999 Mar;40(3):458-61 - PubMed
  7. Am J Dermatopathol. 2000 Oct;22(5):413-7 - PubMed
  8. Nature. 2004 Apr 1;428(6982):486 - PubMed
  9. Burns. 2010 Mar;36(2):152-63 - PubMed
  10. Bull Soc Ophtalmol Fr. 1971 May-Jun;71(5-6):536-41 - PubMed
  11. Ann Pharmacother. 2000 Jan;34(1):32-4 - PubMed
  12. JAMA. 1987 Apr 24;257(16):2207-8 - PubMed
  13. Br Med J (Clin Res Ed). 1985 Jan 12;290(6462):113-4 - PubMed
  14. Burns. 2007 Jun;33(4):452-9 - PubMed
  15. Arch Dermatol. 1993 Jan;129(1):92-6 - PubMed
  16. Epilepsia. 1983 Aug;24(4):440-3 - PubMed
  17. Pediatr Dermatol. 2002 Jan-Feb;19(1):52-5 - PubMed
  18. Orphanet J Rare Dis. 2010 Dec 16;5:39 - PubMed
  19. N Engl J Med. 1995 Dec 14;333(24):1600-7 - PubMed
  20. J Hum Nutr Diet. 2006 Apr;19(2):152-3; author reply 153-5 - PubMed
  21. Arch Dermatol. 1990 Jan;126(1):43-7 - PubMed
  22. J Am Acad Dermatol. 1991 Jul;25(1 Pt 1):69-79 - PubMed
  23. Burns. 2001 Sep;27(6):652-5 - PubMed
  24. Br J Dermatol. 1997 Apr;136(4):645-6 - PubMed
  25. J Invest Dermatol. 2000 Aug;115(2):149-53 - PubMed
  26. Arch Dermatol. 2000 Mar;136(3):410-1 - PubMed
  27. Br J Dermatol. 2005 Aug;153(2):241-53 - PubMed
  28. Acta Med Port. 2004 Mar-Apr;17(2):129-40 - PubMed
  29. Br J Plast Surg. 2005 Jun;58(4):504-10 - PubMed
  30. J Invest Dermatol. 2008 Jan;128(1):35-44 - PubMed
  31. Burns. 1996 Jun;22(4):275-8 - PubMed
  32. Int J Dermatol. 2007 Oct;46(10):1092-4 - PubMed
  33. Crit Care Med. 2011 Jun;39(6):1521-32 - PubMed
  34. JAMA. 1987 Apr 24;257(16):2171-5 - PubMed
  35. Br J Dermatol. 1956 Nov;68(11):355-61 - PubMed

Publication Types